HI
BBC icon

Harbour Investments’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

Harbour Investments’s Portfolio BBC Stock Details BBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-232
Closed -$6.48K – 3494
2024
Q3 		$6.48K Sell
232
-78
-25% -$2.15K ﹤0.01% 2538
2024
Q2 		$7.83K Hold
310
– – ﹤0.01% 2361
2024
Q1 		$9.03K Sell
310
-126
-29% -$3.45K ﹤0.01% 2265
2023
Q4 		$10.7K Hold
436
– – ﹤0.01% 2120
2023
Q3 		$8.56K Sell
436
-303
-41% -$6.73K ﹤0.01% 2092
2023
Q2 		$17.7K Hold
739
– – ﹤0.01% 1804
2023
Q1 		$16.2K Hold
739
– – ﹤0.01% 1818
2022
Q4 		$18.5K Sell
739
-80
-10% -$1.99K ﹤0.01% 1714
2022
Q3 		$18K Hold
819
– – ﹤0.01% 1694
2022
Q2 		$18K Buy
+819
New +$18K ﹤0.01% 1694
2021
Q4 		$64K Sell
1,654
-2,804
-63% -$120K ﹤0.01% 1147
2021
Q3 		$204K Sell
4,458
-124
-3% -$5.8K 0.01% 1011
2021
Q2 		$229K Sell
4,582
-245
-5% -$12K 0.01% 979
2021
Q1 		$248K Buy
+4,827
New +$264K 0.01% 880

Other funds holding BBC

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

Harbour Investments's BBC Position: Q4 2024 in Review

Harbour Investments sold out of Virtus Biotech Clinical Trials ETF (BBC) in Q4 2024, closing a stake of 232 shares — an estimated $6.48K sold.

Harbour Investments first reported a position in BBC in Q1 2021 and held it in 14 quarters. The position peaked at $248K in Q1 2021. 9 funds tracked by Wall St. Rank hold BBC as of Q4 2024.

  • Harbour Investments reported no remaining Virtus Biotech Clinical Trials ETF position as of Q4 2024 after selling out during the quarter.
  • Harbour Investments sold 232 Virtus Biotech Clinical Trials ETF shares in Q4 2024, an estimated $6.48K.
  • Harbour Investments first reported a position in Virtus Biotech Clinical Trials ETF in Q1 2021 and held it in 14 quarters.
  • Harbour Investments's Virtus Biotech Clinical Trials ETF position peaked at $248K in Q1 2021.
  • 9 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q4 2024.

Based on Harbour Investments's 13F filing for Q4 2024, filed 10 Feb 2025.